Physician profile
Ahmad Rafi
NPI 1285671487
$4,046.47
in general payments reported to CMS, 2019-2025
24 companies · $23.03 in 2025
The $23.03 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,998 · 2020: $658 · 2021: $150 · 2022: $70.53 · 2023: $68.82 · 2024: $78.49 · 2025: $23.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,559.56 | 2019 | |
| Stimwave Technologies Incorporated | $670.52 | 2019-2020 | |
| Vertos Medical, INC. | $369.11 | 2019-2020 | |
| Boston Scientific Corporation | $299.29 | 2020-2021 | |
| Nevro Corp. | $223.79 | 2020-2024 | Senza |
| Medtronic USA, INC. | $195.08 | 2019-2020 | |
| Daiichi Sankyo INC. | $175.10 | 2019 | |
| Allergan, INC. | $124.55 | 2019-2021 | |
| Spinal Simplicity, LLC | $66.52 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $50.24 | 2019-2021 | |
| Bioventus LLC | $36.55 | 2019-2021 | |
| Nalu Medical, INC. | $36.20 | 2023 | Nalu Neurostimulation System |
| Medtronic, INC. | $35.96 | 2023-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Grt US Holding, INC. | $33.70 | 2021-2022 | |
| Tersera Therapeutics LLC | $23.32 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $23.13 | 2019 | |
| Averitas Pharma INC. | $23.03 | 2025 | Qutenza |
| Shionogi INC | $16.67 | 2019 | |
| Saluda Medical Americas, INC. | $16.59 | 2024 | Evoke |
| Teva Pharmaceuticals USA, INC. | $16.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.83 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.33 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.26 | 2019 | |
| Collegium Pharmaceutical, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Rafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.